Biomarkers of behavioral symptoms must be studied in all disease stages. We discuss potential applications of biofluid biomarkers for neuropsychiatric diagnoses in dementia with Lewy bodies and in preclinical and prodromal Alzheimer's disease.
Moderators: Zahinoor Ismail, Fabricio Oliveira
Panelists: Fabrizia D'Antonio, Maryam Ghahremani
To register for the live event, please visit: https://alz-org.zoom.us/webinar/register/WN_nOEKLsajQ3GeLR-WgbMPrw